These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7563330)

  • 1. Changing concepts on pathology and therapy for transitional cell carcinoma.
    Cummings KB
    J Urol; 1995 Nov; 154(5):1717-8. PubMed ID: 7563330
    [No Abstract]   [Full Text] [Related]  

  • 2. Salvage systemic therapy for advanced urothelial carcinoma: on the cusp of a sea change?
    Sonpavde G; Bellmunt J
    Oncologist; 2015 May; 20(5):461-3. PubMed ID: 25845991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UTUC in 2017: Emerging evidence on treating upper tract urothelial cancer.
    Grande P; Rouprêt M
    Nat Rev Urol; 2018 Feb; 15(2):73-74. PubMed ID: 29182602
    [No Abstract]   [Full Text] [Related]  

  • 4. Urothelial carcinoma of the upper urinary tracts: current knowledge and future perspectives.
    Margulis V; Hutchinson R; Krabbe LM
    Minerva Urol Nefrol; 2016 Aug; 68(4):348-9. PubMed ID: 27404376
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial Comment to Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study.
    Mitsui Y
    Int J Urol; 2015 Jul; 22(7):643-4. PubMed ID: 25903446
    [No Abstract]   [Full Text] [Related]  

  • 6. Surgical consolidation of initially unresectable urothelial carcinoma: an incremental opportunity to cure.
    Siefker-Radtke AO
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1701-3. PubMed ID: 19954279
    [No Abstract]   [Full Text] [Related]  

  • 7. Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery.
    Chung SD; Lai MK; Chueh SC
    BJU Int; 2008 Aug; 102(4):519. PubMed ID: 18699962
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current developments in urothelial carcinoma].
    Niegisch G; Kramer M
    Urologie; 2024 Oct; 63(10):975-976. PubMed ID: 39373754
    [No Abstract]   [Full Text] [Related]  

  • 9. First-line Immunotherapy in Metastatic Urothelial Carcinoma.
    Ghatalia P; Zibelman M; Geynisman DM; Plimack ER
    Eur Urol Focus; 2020 Jan; 6(1):45-47. PubMed ID: 31103603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Management of Invasive Bladder and Upper Tract Urothelial Cancer.
    Holzbeierlein JM
    Urol Clin North Am; 2018 May; 45(2):xv-xvi. PubMed ID: 29650145
    [No Abstract]   [Full Text] [Related]  

  • 11. Urological cancers. Preface.
    McConkey DJ; Dinney C
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):267. PubMed ID: 20013034
    [No Abstract]   [Full Text] [Related]  

  • 12. [Optimizing treatment of advanced urologic malignancies].
    Heidenreich A; Ohlmann CH; Ozgür E; Pfister D; Sahi D; Thüer D; Engelmann UH
    Urologe A; 2007 Sep; 46(9):1278-84. PubMed ID: 17628781
    [No Abstract]   [Full Text] [Related]  

  • 13. Transitional cell carcinoma.
    Narayan P
    J Urol; 1996 Aug; 156(2 Pt 1):389-90. PubMed ID: 8683685
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial Comment on "Real-world treatment patterns and quality of life among patients with locally advanced or metastatic urothelial carcinoma living in Saudi Arabia, South Korea, Taiwan, and Turkey".
    Giudice GC; Sonpavde GP
    Int J Urol; 2024 Aug; 31(8):943-944. PubMed ID: 38825971
    [No Abstract]   [Full Text] [Related]  

  • 15. Understanding Adjuvant Therapy for Upper Tract Urothelial Carcinoma.
    Berg SA; Galsky MD
    J Clin Oncol; 2024 May; 42(13):1459-1461. PubMed ID: 38359384
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical studies of chemotherapy for patients with a solitary kidney after nephroureterectomy for advanced upper urothelial transitional cell carcinoma].
    Tsujimura A; Takayama H; Tsukikawa M; Imazu T; Sugao H; Takaha M
    Hinyokika Kiyo; 1995 Mar; 41(3):183-9. PubMed ID: 7741070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endourologic management of upper tract transitional cell carcinoma.
    Clark PE; Streem SB
    ScientificWorldJournal; 2004 Jun; 4 Suppl 1():62-75. PubMed ID: 15349530
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter to the editor for the article "Molecular urothelial tumor cell subtypes remain stable during metastatic evolution".
    Song Y; Peng Y; Xu T
    World J Urol; 2023 Oct; 41(10):2869-2870. PubMed ID: 37516671
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of upper urinary tract urothelial carcinoma.
    Sun M; Abdo A; Abdollah F; Schmitges J; Thuret R; Jeldres C; Shariat SF; Perrotte P; Karakiewicz PI
    Expert Rev Anticancer Ther; 2010 Dec; 10(12):1955-65. PubMed ID: 21110761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapeutic targets in advanced urothelial carcinoma.
    Rouanne M; Loriot Y; Lebret T; Soria JC
    Crit Rev Oncol Hematol; 2016 Feb; 98():106-15. PubMed ID: 26589398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.